Related by context. All words. (Click for frequent words.) 75 plus medroxyprogesterone acetate 73 conjugated equine estrogens 72 tibolone 70 medroxyprogesterone acetate 69 antiandrogen 68 conjugated estrogen 68 polytherapy 68 flutamide 68 LNG IUS 68 norgestimate 67 Postmenopausal 67 β blockers 67 venlafaxine Effexor 67 serum estradiol 67 APTIVUS r 67 androgen suppression 66 norethindrone acetate 66 hormone therapy estrogen 66 mammographic density 66 endometrial hyperplasia 66 containing drospirenone 66 CYP#D# inhibitor 66 pyridostigmine 66 cilostazol 66 colorectal adenoma 66 atypical antipsychotic medications 66 LYSTEDA 66 medroxyprogesterone acetate MPA 66 TEAEs 65 conjugated estrogens 65 Progestin 65 oxycodone CR 65 paroxetine sertraline 65 estrogen ethinyl estradiol 65 norethindrone 65 lamotrigine 65 ARIXTRA 65 nonvertebral fractures 65 desvenlafaxine succinate 65 atorvastatin #mg 65 octreotide LAR 65 depot medroxyprogesterone acetate 65 aspirin clopidogrel 65 titrated glipizide 65 oxcarbazepine 65 relapsed MM 65 antiandrogens 65 oral prednisolone 65 medroxyprogesterone 65 venous thromboembolic events 65 inhaled budesonide 64 tenofovir emtricitabine 64 GnRH agonists 64 thromboembolic events 64 oral antidiabetes 64 beta carotene supplementation 64 corticosteroid dose 64 recurrent venous thromboembolism 64 abacavir lamivudine 64 ziprasidone 64 ATACAND 64 anastrazole 64 lipid lowering medications 64 postmenopausal hormone 64 endometrial carcinoma 64 lipid lowering agents 64 valacyclovir 64 benazepril 64 systemic corticosteroid 64 antidiabetic medications 64 ß blockers 64 intravenous bisphosphonates 64 Heavy menstrual bleeding 64 mesalamine granules 64 loop diuretics 64 prednisone prednisolone 64 ddI 64 PREMPRO 64 antiepileptic drugs AEDs 64 solifenacin 64 mycophenolate mofetil 64 rFSH 64 antiemetics 64 progestogen 64 ibandronate 63 postintervention 63 analgesic medications 63 GnRH agonist 63 beta blocker therapy 63 irbesartan 63 suppressive therapy 63 synthetic progestin 63 antiarrhythmic drug 63 biologic DMARD 63 venlafaxine XR 63 TDF FTC 63 antidiabetic medication 63 sotalol 63 paricalcitol 63 FASLODEX 63 salmeterol fluticasone 63 HMG CoA reductase inhibitors 63 ovulatory cycles 63 poor metabolizers 63 amisulpride 63 symptomatic VTE 63 #mg dose [003] 63 oestradiol 63 oral contraceptive pills 63 tamsulosin 63 SSRI SNRI 63 mycophenolate mofetil MMF 63 paroxetine Paxil 63 QTc 63 RLAI 63 cholinesterase inhibitor 63 BYSTOLIC 63 LHRH agonists 63 acromegalic patients 63 cranial irradiation 63 serum concentrations 63 anticholinergic agents 63 dalteparin 63 premenstrual syndrome PMS 63 raloxifene Evista 63 plus progestin 63 lipid lowering drugs 63 thromboprophylaxis 63 bezafibrate 63 hip BMD 63 abacavir Ziagen 63 nalbuphine 63 Serious adverse reactions 63 antioxidant supplementation 63 serum lipid levels 62 NPH insulin 62 metformin sulfonylurea 62 CVD mortality 62 citalopram Celexa 62 postmenopausal hormone replacement 62 NMDA receptor antagonists 62 lumbar spine BMD 62 terazosin 62 5-FU/LV 62 budesonide pMDI 62 chemoradiation therapy 62 clomipramine 62 antiepileptics 62 nadroparin 62 gadobutrol 62 advanced adenoma 62 COZAAR 62 INVEGA ® 62 REYATAZ ritonavir 62 vulvovaginal atrophy 62 ritonavir boosted atazanavir 62 EMEND 62 certolizumab 62 Postoperative complications 62 angiotensin converting enzyme inhibitors 62 aromatase inhibitor therapy 62 recurrent VTE 62 chlorthalidone 62 ritonavir boosted 62 ACEIs 62 NUCYNTA R 62 tipranavir r 62 SHBG levels 62 anticoagulant warfarin 62 tolterodine 62 tumor histology 62 pregabalin 62 ginkgo biloba extract 62 efavirenz EFV 62 haloperidol Haldol 62 pamidronate 62 transdermal estrogen 62 BENICAR HCT 62 adenoma recurrence 62 arterial thromboembolic events 62 TMP SMX 62 saline placebo 62 See CLINICAL PHARMACOLOGY 62 endometriosis ovarian cysts 62 Ranolazine 62 Danazol 62 HIV HCV coinfected 62 progestagen 62 triptan therapy 62 thiazide 62 liver transplant recipients 62 antiplatelet drugs 62 urinary calcium 62 IIIa inhibitor 62 sulphonylureas 62 protease inhibitors PIs 62 fluticasone salmeterol 62 folic acid supplement 62 mutated K ras 62 zonisamide SR 62 labetalol 62 intravitreal injections 62 aspirin NSAIDs 62 colorectal adenomas 62 steroid dexamethasone 62 indapamide 62 antiplatelet medications 62 #mg/day [002] 62 divalproex sodium 61 salmeterol fluticasone propionate 61 ursodeoxycholic acid 61 ARB telmisartan 61 Interferon beta 1b 61 nabilone 61 protease inhibitor PI 61 estrogen progestin therapy 61 RISPERDAL ® 61 PRADAXA #mg 61 Androgel R 61 olmesartan 61 methotrexate monotherapy 61 HMG CoA reductase inhibitor 61 goserelin 61 glatiramer acetate 61 advanced adenomas 61 overactive bladder symptoms 61 oral antidiabetic medication 61 oral bisphosphonate 61 nonpregnant women 61 antithrombotic therapy 61 thiazide diuretics 61 containing levonorgestrel 61 hematologic toxicity 61 Erythropoietic therapies may 61 LOVENOX R 61 TT genotype 61 oral prednisone 61 zoledronate 61 recombinant FSH 61 recurrent DVT 61 diuretic chlorthalidone 61 #mg doses [002] 61 vaginal estrogen 61 inactive placebo 61 tamoxifen Nolvadex ® 61 trospium 61 aldosterone antagonist 61 nulliparous women 61 LEXIVA 61 androgen deprivation 61 Vagifem 61 IOP lowering 61 mild renal insufficiency 61 clodronate 61 danazol 61 cholestyramine 61 Pemetrexed 61 montelukast 61 Memory Study WHIMS 61 Subgroup analysis 61 myopathy rhabdomyolysis 61 inflammatory biomarkers 61 Febrile neutropenia 61 #mg #mg #mg [003] 61 Viread Emtriva 61 antidepressant paroxetine 61 ximelagatran 61 tamoxifen raloxifene 61 COPD exacerbations 61 FOSRENOL ® 61 biologic DMARDs 61 bupropion SR 61 zidovudine lamivudine 61 mg p = 61 strontium ranelate 61 baseline HbA1c 61 Avandia Actos 61 Posaconazole 61 FROVA 61 fewer uterine cancers 61 #mg/m# [001] 61 GG genotype 61 MIRAPEX 61 amifostine 61 ticlopidine 61 acarbose 61 prolactin elevation 61 triiodothyronine 61 endometrial thickness 61 thromboembolisms 61 parous women 61 CsA 61 Drospirenone 61 CYP#A# inhibitors 61 dosage regimens 61 SCIg 61 tacrolimus ointment 61 lipid lowering medication 61 androgen ablation 61 venous thromboembolic disease 61 pentoxifylline 61 SSRI antidepressant 61 recurrent UTI 61 thromboembolism 61 selenium supplementation 61 valsartan Diovan 61 somatostatin analogs 61 extrapyramidal symptoms 61 ertapenem 61 loop diuretic 61 nonvertebral fracture 61 glyceryl trinitrate 61 ritonavir boosted lopinavir 61 abnormal mammograms 61 ARCOXIA 61 periprocedural MI 61 estramustine 61 MAGE A3 ASCI 61 postoperative mortality 61 betamethasone 61 postmenopausal hormone therapy 61 tricyclic antidepressants 61 prednisone prednisolone plus 61 aciclovir 61 psychiatric comorbidity 61 unfractionated heparin UFH 61 lidocaine gel 61 zolmitriptan 61 maximal doses 61 ORTHO EVRA R 61 micronized progesterone 61 anticonvulsant medication 61 angiographic restenosis 61 hyperphenylalaninemia HPA due 61 postoperative chemotherapy 61 impair fertility 61 risedronate 61 Teriflunomide 61 menstrual bleeding 61 oral contraceptive OC 61 eplerenone 61 NNT = 61 dysmenorrhoea 61 phytoestrogen intake 60 Adjuvant chemotherapy 60 postoperative AF 60 β blocker 60 BEXXAR Therapeutic Regimen 60 Mg Uk 60 mg/#.# mg [001] 60 hormone levonorgestrel 60 achieved ACR# 60 mycophenolate 60 microg 60 progestin therapy 60 thiazide diuretic 60 pharmacologically active isomer 60 direct thrombin inhibitors 60 #mg dose [002] 60 racemic albuterol 60 Tibolone 60 tiagabine 60 #.#g/day 60 shorter telomere length 60 indinavir 60 mitoxantrone 60 insulin detemir 60 alfuzosin 60 nonsignificant difference 60 coadministration 60 KAPIDEX 60 rhGH 60 Thalomid ® 60 selegiline 60 letrozole Femara 60 typical antipsychotics 60 VIIBRYD 60 Gonal f 60 pegaptanib 60 chlamydial infection 60 estrogen estradiol 60 RAS blockers 60 tricyclic antidepressants TCAs 60 prucalopride 60 venous thromboembolisms 60 thromboembolic 60 MEVACOR 60 leiomyomas 60 Calcium intake 60 hematopoietic cancers 60 HbA1C levels 60 candesartan cilexetil 60 tenofovir Viread 60 remifentanil 60 hMG 60 ACE Inhibitors 60 pravastatin Pravachol 60 timepoints 60 oral contraception 60 nasopharyngitis headache 60 tricyclic anti depressants 60 moderate renal impairment 60 dysmenorrhea 60 noscapine 60 Celecoxib APC trial 60 DHA supplementation 60 PREZISTA ritonavir 60 NOLVADEX 60 anticonvulsant medications 60 hydroxychloroquine 60 milrinone 60 NMIBC 60 plasma homocysteine levels 60 carotid stenosis 60 severe exacerbations 60 Betaferon R 60 attain statistical significance 60 NATRECOR R 60 vasomotor symptoms 60 periprocedural 60 transrectal ultrasound guided 60 CC genotype 60 daily subcutaneous injections 60 mg simvastatin 60 newer atypical antipsychotics 60 concomitant medications 60 trials RCTs 60 REVLIMID ® 60 neuroleptic 60 hormone therapy HT 60 tolterodine ER 60 folic acid vitamin B6 60 hypoglycaemic episodes 60 doxorubicin cyclophosphamide 60 female hormones estrogen 60 NNRTI resistance 60 prospective multicentre 60 nadolol 60 APTIVUS ritonavir 60 pharmacologic treatments 60 cerebral microbleeds 60 beta carotene supplements 60 euthyroid 60 antihypertensive medication 60 thiopurine 60 Double Blind Randomized 60 definite stent thrombosis 60 Helicobacter pylori eradication 60 NUCYNTA TM 60 dose paroxetine mesylate 60 HER2 expression 60 antihypertensive medications 60 deep venous thromboses 60 EXJADE 60 cabergoline 60 paclitaxel eluting stents 60 trimethoprim sulfamethoxazole 60 GH deficiency 60 FRAGMIN 60 antifibrinolytic 60 mg d 60 pimecrolimus cream 60 P = .# 60 oocytes retrieved 60 morphometric vertebral fractures 60 atazanavir ritonavir 60 serum homocysteine 60 events TEAEs 60 fibrate drugs 60 hormones estrogen 60 q#h 60 AChE inhibitors 60 progestogens 60 opioid dependent 60 #mg/day [001] 60 Paxil paroxetine 60 vaginal progesterone gel 60 recurrent miscarriage 60 glucocorticoid induced osteoporosis 60 comorbid psychiatric disorders 60 postmenopausal osteoporotic women 60 dyspareunia 60 interferon alfa 2b 60 oral bisphosphonates 60 antimuscarinic 60 Natazia 60 non aspirin NSAIDs 60 FDA defined valvulopathy 60 cervicitis 60 serum BDNF 60 mg Pycnogenol 60 teratogenic 60 isoflavone supplement 60 adriamycin 60 baseline LDH 60 piperacillin tazobactam 60 perimenopausal women 60 bioavailable testosterone 60 anticholinergics 60 olanzapine quetiapine 60 Doxil ® 60 finasteride Proscar 60 HGPIN 60 weekly intravenous infusions 60 lipid lowering therapy 60 candesartan 60 anticoagulation therapy 60 LT NS# 60 echocardiographic parameters 60 oophorectomy 60 spirometric 60 Subgroup analyzes 60 oral anticoagulant therapy 60 antidepressants SSRIs 60 telaprevir dosing 60 thrombotic events 60 adalimumab Humira 60 Schaffir 60 progestins 60 HbA 1c levels 60 irregular menstrual periods 60 adjunctive placebo 60 tricyclic antidepressant 60 ABC/3TC 60 amenorrhoea 60 efalizumab 60 STRIDE PD 60 oral diclofenac 60 locoregional recurrence 60 weekly subcutaneous injections 60 antenatal corticosteroids 60 antidiabetic drugs 60 drospirenone containing 60 conventional antipsychotics 60 myocardial infarctions MIs 60 QVAR R 60 oral contraceptive pill 60 mycophenolic acid 60 nortriptyline 60 clomiphene 60 moderate hepatic impairment 60 fibroids endometriosis 60 irregular menstrual cycles 60 oxycodone IR 60 piroxicam 60 plasma folate 60 gemfibrozil 60 recurrent glioblastoma multiforme 60 rosuvastatin Crestor 60 corrected QT interval 60 #mg dose [001] 60 confidence interval #.#-#.# 60 follicular phase 60 B vitamin supplementation 60 folinic acid 60 nephrotoxic 60 receptor blocker 60 COREG 60 intravenous dosing 60 beclomethasone 60 IM progesterone 60 nonaspirin 60 FluCAM arm 60 buprenorphine implants 60 Hematologic 60 Aggrenox ® 60 Hepatotoxicity 60 MAS XR 60 somatostatin analog 60 MGd 60 nonfatal MI 60 Nebulized 60 aldosterone antagonists 60 spontaneous preterm delivery 60 ezetimibe simvastatin 60 radioiodine therapy 60 μg kg 59 postexposure prophylaxis 59 prospectively stratified 59 symptomatic intracranial 59 TYGACIL 59 pyrazinamide 59 orofacial clefts 59 3TC lamivudine Epivir 59 plasma selenium 59 placebo dexamethasone 59 ethambutol 59 oral alendronate 59 infliximab monotherapy 59 serum leptin 59 CLINICAL STUDIES 59 % CI #.#-#.# [003] 59 postmenopausal estrogen 59 cyproterone acetate 59 bicalutamide 59 serum phosphate levels 59 vaginal hysterectomy 59 biochemical relapse 59 otamixaban 59 APTIVUS R 59 enalapril 59 Protease Inhibitors 59 sodium valproate 59 MAO inhibitors 59 rFVIIa 59 calcium antagonists 59 QTc intervals 59 oesophageal adenocarcinoma 59 mg BID dose 59 mIU ml 59 CIMZIA R 59 EDARBI 59 histologic subtype 59 REMINYL ® 59 SGPT 59 APTIVUS 59 Selective serotonin reuptake inhibitors 59 DOXIL 59 alpha blockers 59 aromatase inhibitors AIs 59 perioperatively 59 PASI scores 59 dizziness nausea diarrhea 59 symptom exacerbation 59 FOLFIRI alone 59 isoproterenol 59 torsade de pointes 59 dexamethasone Decadron 59 lenalidomide dexamethasone 59 antenatal depression 59 inhaled glucocorticoids 59 inert placebo 59 buprenorphine naloxone 59 antidiabetic drug 59 nelfinavir 59 oral contraceptives OCs 59 PLX STROKE targeting 59 pravastatin therapy 59 ACTEMRA TM 59 imipramine Tofranil 59 undergone hysterectomies 59 genotypic resistance 59 anti androgen 59 meta regression 59 oral anticoagulants 59 mu opioid agonist analgesics 59 external beam radiotherapy 59 Oral contraceptives 59 prenatal multivitamin 59 palivizumab 59 dexrazoxane 59 NATRECOR ® 59 conventional DMARDs 59 Calcium vitamin D 59 irregular menses 59 drospirenone 59 detrusor overactivity 59 thyrotropin 59 combined estrogen progestogen 59 elevated LDH 59 idraparinux 59 vasodilators 59 fluoxetine Prozac 59 PRADAXA 59 boosted protease inhibitor 59 Uprima 59 luteal 59 systemic corticosteroids 59 Natalizumab 59 Comorbidities 59 antihypertensive therapy 59 Velcade bortezomib 59 long acting bronchodilator 59 dosing frequency 59 underwent CABG 59 atherothrombotic events 59 nevirapine Viramune 59 urolithiasis 59 normotensive 59 retrograde ejaculation 59 OAB symptoms 59 SUSTIVA 59 estrogen progestin combination 59 virological failure 59 mu opioid 59 hypercholesterolaemia 59 acitretin 59 hematologic abnormalities 59 ALT flares 59 moderately emetogenic 59 doxazosin 59 Perforomist Inhalation Solution 59 prolactin levels 59 IXEMPRA 59 nonsteroidal antiinflammatory drugs 59 IFN beta 59 GP IIb IIIa inhibitors 59 abdominal hysterectomy 59 dietary calcium intake 59 progestin hormone 59 Fondaparinux 59 Platinol ® cisplatin 59 pretreatment serum 59 4mg/kg 59 hypothalamic amenorrhea 59 antithyroid 59 pegIFN 59 multivariable adjusted 59 Femara letrozole 59 glyburide 59 Effexor venlafaxine 59 dexmethylphenidate 59 phenytoin 59 aripiprazole Abilify 59 colorectal liver metastases 59 IFN alfa 59 endogenous hormones 59 MMSE score 59 unresectable HCC 59 bacterial vaginosis BV 59 mitoxantrone plus 59 bilateral oophorectomy 59 amoxicillin clavulanate 59 emtricitabine tenofovir 59 pCR 59 acetaminophen ibuprofen 59 estrone 59 intrauterine contraception 59 Estrogens 59 ethinylestradiol 59 EFFEXOR XR 59 polyp recurrence 59 Vimpat R 59 Topiramate 59 menopausal symptom 59 Mg Usa 59 DMPA 59 ketorolac 59 preoperative chemotherapy 59 nondepressed 59 suppressing ovulation 59 dopaminergic therapy 59 EBRT 59 coronary calcification 59 lactulose 59 dose Iluvien 59 breast tenderness bloating 59 cefazolin 59 Pegylated Liposomal Doxorubicin 59 beta interferons 59 alteplase 59 Vivelle Dot 59 PEGINTRON TM 59 renoprotective 59 thyrotropin levels 59 hypogonadal men 59 antiepileptic drug 59 oral contraceptives 59 hematological adverse 59 sertraline Zoloft 59 d4T stavudine Zerit 59 LEXIVA r 59 valproate 59 clotrimazole 59 antiretroviral naive 59 placebo controlled trials 59 undergoing coronary angiography 59 LUTS 59 serum testosterone 59 serum retinol 59 methotrexate therapy 59 potassium sparing diuretics 59 postprocedure 59 antiretroviral naïve 59 Carvedilol 59 Lamotrigine 59 chronic prostatitis 59 Atomoxetine 59 nifedipine 59 atherosclerotic renal artery stenosis 59 TOPAMAX ® 59 recurrent genital herpes 59 KIF6 carriers 59 Peg IFN 59 d4T 59 renal toxicity 59 ritonavir boosted protease inhibitor 59 oral rivaroxaban 59 dyslipidaemia 59 plasma homocysteine 59 symptomatic BPH 59 HCV SPRINT 59 tamoxifen therapy 59 nitroprusside 59 anticholinergic drugs 59 thyroid hormone levels 59 FSAD 59 BoNTA 59 mesalazine 59 H2 blockers 59 DES implantation 59 QTc interval 59 tirofiban 59 nonmelanoma skin cancers 59 Proellex TM 59 umol L 59 Peginterferon 59 multivariate adjustment 59 agomelatine 59 Fibrates 59 nonhematologic adverse reactions 59 buproprion 59 Hypotension 59 Lysteda 59 Estradiol 59 secondary amenorrhea 59 % CI #.#-#.# [008] 59 antiepileptic drugs 59 H2 antagonists 59 noncardiovascular mortality 59 urinary tract symptoms LUTS 59 Valcyte tablets 59 #mg BID [001] 59 papillary renal cell carcinoma 59 Oral contraceptive 59 intra articular injection 59 Tasigna prolongs 59 acetazolamide 59 histological subtype 59 elevated ALT 59 lipid elevations 59 Non Steroidal Anti Inflammatory 59 anticonvulsants 59 leflunomide 59 IELT 59 mTOR inhibitors 59 ethinyl estradiol tablets 59 Pharmacokinetics PK 59 risedronate Actonel 59 EGFRIs 59 mg Proellex 59 transdermal estradiol 59 platelet inhibitor 59 mg hydrochlorothiazide 59 oral naltrexone 59 LATUDA 59 estrogen progestin 59 haemorrhagic stroke 59 terbutaline 59 bacterial prostatitis 59 endoxifen 59 sevelamer 59 estradiol valerate 59 antihypertensive drugs 59 MULTAQ 59 ALISTA 59 epoetin beta 59 CLINICAL PHARMACOLOGY 59 TRIZIVIR 59 % Confidence Interval 59 glucocorticoid therapy 59 microdose 59 CrCl 59 HC APAP 59 Nocturia 59 fibrinolytic 59 Kaplan Meier analysis 59 menopausal hormone therapy 59 hypoglycemic episodes 59 Henrik Leffers 59 AGILECT R 59 urate lowering therapy 59 severe periodontitis 59 QTc prolongation 59 serum selenium 59 EURIDIS 59 insulin glulisine 59 KETEK 59 heavy menstrual bleeding 59 tipranavir ritonavir 59 Prilosec omeprazole 59 antidepressants fluoxetine 58 vitamin D inadequacy 58 mg eq 58 anemia hemoglobin 58 Glatiramer acetate 58 pharmacokinetic interactions 58 corticosteroid therapy 58 Valproate 58 immunomodulatory therapy 58 multivariate analyzes 58 REYATAZ r arm 58 Prelox 58 ORTHO TRI CYCLEN LO 58 caspofungin 58 venous blood clots 58 tapentadol IR 58 estrogen therapy 58 pantoprazole Protonix 58 virologic failure 58 headache abdominal pain 58 serum PTH 58 subtrochanteric 58 nicardipine 58 CHD mortality 58 breast tenderness 58 Triptan 58 carotid IMT 58 cisplatin chemotherapy 58 Hormonal therapy 58 oral ibandronate 58 levonorgestrel releasing 58 norelgestromin 58 rosuvastatin #mg 58 Thal Dex 58 gliclazide 58 nonnucleoside reverse transcriptase inhibitors 58 benign prostatic hypertrophy 58 Exemestane 58 CLA supplementation 58 dosing cohort 58 imiquimod cream 58 oral hypoglycemic 58 Lamictal XR 58 mitoxantrone chemotherapy 58 #mg q8h 58 bolus dose 58 hormone receptor negative 58 Adjunctive 58 DULERA 58 aripiprazole 58 NSAID 58 adrenal suppression 58 retrospective cohort 58 antibiotic prophylaxis 58 omeprazole Prilosec 58 Adenomas 58 intima media thickness 58 zoledronic acid Zometa 58 trastuzumab Herceptin ® 58 hepatic metastases 58 LMWH 58 statin monotherapy 58 Venlafaxine 58 premenopausal 58 ENDOMETRIN 58 lipid lowering therapies 58 anthracycline taxane 58 del 5q MDS 58 NUCYNTA ® 58 lanthanum carbonate 58 pioglitazone Actos 58 stavudine d4T 58 Cariprazine 58 thromboembolic complications 58 eszopiclone 58 EEG abnormalities 58 HIV uninfected 58 adjunctive ABILIFY 58 K ras mutations 58 hepatic enzyme 58 ergot derivatives 58 teriflunomide 58 oral corticosteroids 58 FRAGMIN R 58 CAELYX 58 intravenous RSD# 58 Relapsing Remitting Multiple Sclerosis 58 hypomagnesemia 58 azathioprine 58 PONV 58 vaginal atrophy 58 treatment emergent AEs 58 mg kg dose 58 acetaminophen codeine 58 Teriparatide 58 Tigecycline 58 warfarin sodium 58 QTcF 58 diastolic BP 58 hematological parameters 58 GI toxicity 58 homocysteine concentrations 58 DAPT 58 carotid plaque 58 dysglycemia 58 oral levofloxacin 58 paracetamol acetaminophen 58 bupropion XL 58 non valvular atrial 58 thromboembolic disease 58 hepatic insufficiency 58 ARIMIDEX 58 PREZISTA r 58 erection hardness 58 DMARDS 58 atrophic vaginitis 58 chronic idiopathic thrombocytopenic purpura 58 oral anticoagulation